Research Progress of Astragalus in the Treatment of Membranous Nephropathy
DOI:
https://doi.org/10.53469/jcmp.2024.06(12).10Keywords:
Membranous nephropathy, Astragalus, Research progressAbstract
The basic pathogenesis of membranous nephropathy (MN) is the primary deficiency accompanied by solid deficiency. The deficiency of spleen and kidney is the primary and the symptom of rheumatism and stasis. Astragalus is the essential medicine for tonifying spleen and kidney. In the treatment of membranous nephropathy, Astragalus can play the role of tonifying spleen and kidney, detumifying water, dispelling pathogenic wind and promoting blood flow. Its classic formula has also been widely used in the treatment of membranous nephropathy. This article reviews the research status of astragalus in MN treatment.
References
Zhang Youkang, Li Ying. Diagnosis and treatment of membranous nephropathy [J]. Chinese electronic Journal of Nephropathy Research, 2013, 2(01):5-10.
LIU W, GAO C, LIU Z, et al. Idiopathic Membranous Nephropathy: Glo-merular Pathological Pattern Caused by Extrarenal Immunity Activity [J]. Front Immunol, 2020, 11: 1846.
Liu Jianfang, Ren Xiongfei, LIU Guangzhen. New progress in pathogenesis of membranous nephropathy [J]. The world's latest medical information digest, 2018, 18(45):38-40.
Sun Xinru, WANG Yuefen, LIU Mengchao, et al. Wang Yuefen based on "Gowanchen fodder" stage treatment of membranous nephropathy [J/OL]. Journal of Traditional Chinese Medicine:1-5 [2024-12-02].
Hoxha E, Reinhard L, Stahl RAK. Membranous nephropathy: new pathogenic mechanisms and their clinical implications. Nat Rev Nephrol. 2022; 18(7): 466-478.
Liu Haoyu, Wang Hao, Zhang Jianing, et al. Differentiation and treatment of idiopathic membranous nephropathy based on "treating qi first in treating water" [J]. Journal of Traditional Chinese Medicine, 202, 65(21):2259-2263.
He Zhihua, Wang Lihua. Research on pathogenesis of membranous renal disease [J]. Journal of Clinical Nephrology, 2019, 22(05):423-428.
Liu Baoli, Zhong Yifei, Liu Weijing, et al. Discussion on clinical predominance diseases of traditional Chinese medicine -- membranous nephropathy [J]. Chinese Journal of Experimental Formulae, 2021, 27(16): 185-190.
Chen Yiping, Xie Yuansheng, Liu Baoli, et al. Diagnosis and treatment of membranous nephropathy with Chinese and Western medicine [J]. Chinese Journal of Integrated Traditional and Western Nephropathy, 2024, 25(01): 92-94.
WEI Shuwu, Sun Weiwei, Jiang Weimin. Liu Yuning in the treatment of idiopathic membranous nephropathy based on the principle of "break, equal, balance" [J]. Chinese Journal of Integrative Nephropathy, 2022, 23 (10): 850-852.
Bai Donghai, Lu Anming, Xie Xuan, et al. Professor Wang Baokui's experience in treating membranous nephropathy with raw Astragalus [J]. Global Chinese Medicine, 2018, 11 (06): 918-920.
Su Haixiao, Hou Jian, Liu Qifeng, et al. Research progress on antiviral material basis and mechanism of Astragalus [J/OL]. Chinese Journal of Traditional Chinese Medicine: 1-16 [2024-11-19].
Liu Li, LEI Genping,. The mechanism of Qidi Gushen prescription in the treatment of idiopathic membranous nephropathy [J]. Journal of Traditional Chinese Medicine, 2019, 39(07):1428-1432
Cao Boning, Wang Yaoxian. Application of Astragalus in the treatment of membranous nephropathy [J]. Journal of Traditional Chinese Medicine, 2024, 65(16): 1725-1729+1740.
Ma Mingyang, LI Zhuoxia. Research Progress of effects of Astragalus on immune cells [J]. Popular Science and Technology, 2019, 22(08):61-63.
Pu Yaxin. Effects of imitation wild cultivation under different soil conditions on yield and pharmacodynamic components of Astragalus membranaceus [D]. Shanxi Agricultural University, 2024.
Lu Xun, Wei Minggang. Protective effect of Astragalus polysaccharides on renal interstitial fibrosis in rats [J]. Chinese Journal of Traditional Chinese Medicine, 2014, 29(06):1998-2001.
Wang Mingjuan. Effects of Astragalus polysaccharides on expression of Nephrin and Desmin in mouse glomerular podocytes [J]. Journal of Traditional Chinese Medicine, 2019, 34(12):2621-2625.
Yang Jike, Wang Li, YU Qianhui, et al. Protective effect of Astragalus polysaccharides on chronic renal failure in mice [J]. Tianjin Medicine, 2019, 49(07): 713-718+785-786.
Fu Zhaoxin, LIU Zhongzhu, Zheng Yinan. Research progress of astragaloside in the treatment of kidney diseases [J]. Shanghai Med, 2022, 43(05):43-45+57.
Zhu Jun, Huang Zhilong. Effect of astragaloside on vascular endothelial function in rats with deep venous thrombosis of lower limbs through HIF-1α/iNOS pathway and its mechanism [J]. Journal of Mudanjiang Medical College, 2018, 45(05):28-33.
Cao Yaochen, Ren Guoqing, Hu Jialin, et al. The latest research progress of the mechanism of astragaloside IV renal protection [J]. World Latest Medical Information Digest, 2017, 17(75):102.
Xiang Xelong, Shao Sisi, Chen Yu, et al. Effects of astragaloside on PERK pathway in passive Heymann nephritis rats [J]. New Chinese Medicine, 2018, 50(04): 10-14. 216
Qin Hewei, Sun Mengyan, Wang Mengnan, et al. Effect of astragaloside on Nrf2/HO-1/GPX4 pathway on inhibiting irondeath and improving atherosclerosis in ApoE/-mice [J]. Chinese Journal of Traditional Chinese Medicine, 2024, 49 (13): 3619-3626.
Wang Deqing, Ding Baoguo, Tomas G Neil, et al. Effect of total Astragalus flavones on early atherosclerosis [J]. Chinese Pharmacology Bulletin, 2003(06):637-640.
Su Youla, Chen Guilin. Research progress of flavonoids in Astragalus [J]. Journal of Food Safety and Quality Inspection, 2019, 12(03):849-857.
Wang Dan. Observation on the curative effect of Buyang Huanwu Decoction in the treatment of idiopathic membranous nephropathy [J]. Chinese Journal of Health Standards Management, 2019, 10(05):80-82.
Chang Jiaqiang, Sun Baolin, WANG Shirong. Professor Wang Shirong's experience in the treatment of membranous nephropathy by supplementing Qi and activating blood to eliminate disease [J]. Guangming Chinese Medicine, 2019, 39(19):3874-3877.
Liu Zhanghong, Cheng Jinguo, Chen Ling-Ling, et al. Effect of Buyang Huanwu Decoction on expression of TGF-β1, VEGF and MMP-9 in rats with membranous nephropathy [J]. Zhejiang Journal of Traditional Chinese Medicine, 2019, 55(05):318-320.
Xu Jing, Gao Ning, Wang Meng, et al. Effects of different components of tetrandrhexis on kidney injury in adriamycin-induced nephrotic syndrome rats [J]. Pharmacology and Clinic of Chinese Medicine, 2019, 39(07):59-64.
Zhou Qianqian, Guo Mingwa. Clinical study of modified Fangji Huangqi Decoction combined with Western medicine in treating early renal damage of hypertension [J]. Tianjin Chinese Medicine, 2020, 37(09):1014-1018.
Wang Tiesuo, Zhang Yingtao. Effect of addition and reduction of Fangji Huangqi Decoction on treatment effect and coagulation index of patients with refractory edema of nephrotic syndrome [J]. Journal of Thrombosis and Hemostasis, 2012, 28(03):927-928+931.
Deng Yu, Zhang Qing, Yu Siming. Modern pharmacological study of Shenqi Dihuang Decoction and its application in renal diseases [J]. Liaoning Journal of Traditional Chinese Medicine, 2019, 51(02):217-220.
Wang Tiesuo, Zhang Yingtao. Effect of addition and reduction of Fangji Huangqi Decoction on treatment effect and coagulation index of patients with refractory edema of nephrotic syndrome [J]. Journal of Thrombosis and Hemostasis, 2012, 28(03):927-928+931.
Wang Lei, ZHAO Wenjing, Zhao Jing, et al. Clinical study of Shenqi Dihuang Decoction in the treatment of M-type phosphoesterase A2 receptor antibody positive idiopathic membranous nephropathy [J]. Hebei Traditional Chinese Medicine, 2020, 42(04):522-527.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Niuniu Men, Yun Tian
This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.
